Immunotherapy: a promising alternative

In brief  (20 seconds of reading) :

  • Since 2004, Sophie Lucas, a researcher at the UCLouvain de Duve Institute, has been studying the immune responses that cancer patients can develop against their own tumour
  • She is currently testing a new anti-cancer drug that would strengthen such immune responses
  • This research won the prestigious Academy of Medicine GSK Award, which recognises work in the fields of vaccinology and immunology

Sophie Lucas , a researcher at the UCLouvain de Duve Institute , studies the immune responses that cancer patients can develop against their own tumour. ’In the long run,’ Prof. ...

account creation

POUR LIRE CET ARTICLE, CRÉEZ VOTRE COMPTE

Et prolongez votre lecture, gratuitement et sans engagement.